» Articles » PMID: 39103533

Single-cell Spatial Transcriptomics Reveals Distinct Patterns of Dysregulation in Non-neuronal and Neuronal Cells Induced by the Trem2 Alzheimer's Risk Gene Mutation

Overview
Journal Mol Psychiatry
Date 2024 Aug 5
PMID 39103533
Authors
Affiliations
Soon will be listed here.
Abstract

The R47H missense mutation of the TREM2 gene is a known risk factor for development of Alzheimer's Disease. In this study, we analyze the impact of the Trem2 mutation on specific cell types in multiple cortical and subcortical brain regions in the context of wild-type and 5xFAD mouse background. We profile 19 mouse brain sections consisting of wild-type, Trem2, 5xFAD and Trem2; 5xFAD genotypes using MERFISH spatial transcriptomics, a technique that enables subcellular profiling of spatial gene expression. Spatial transcriptomics and neuropathology data are analyzed using our custom pipeline to identify plaque and Trem2-induced transcriptomic dysregulation. We initially analyze cell type-specific transcriptomic alterations induced by plaque proximity. Next, we analyze spatial distributions of disease associated microglia and astrocytes, and how they vary between 5xFAD and Trem2; 5xFAD mouse models. Finally, we analyze the impact of the Trem2 mutation on neuronal transcriptomes. The Trem2 mutation induces consistent upregulation of Bdnf and Ntrk2 across many cortical excitatory neuron types, independent of amyloid pathology. Spatial investigation of genotype enriched subclusters identified spatially localized neuronal subpopulations reduced in 5xFAD and Trem2; 5xFAD mice. Overall, our MERFISH spatial transcriptomics analysis identifies glial and neuronal transcriptomic alterations induced independently by 5xFAD and Trem2 mutations, impacting inflammatory responses in microglia and astrocytes, and activity and BDNF signaling in neurons.

Citing Articles

Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases.

Liu Z, Song S Genes (Basel). 2025; 16(2).

PMID: 40004464 PMC: 11855287. DOI: 10.3390/genes16020135.


BDNF augmentation reverses cranial radiation therapy-induced cognitive decline and neurodegenerative consequences.

El-Khatib S, Vagadia A, Le A, Baulch J, Ng D, Du M Acta Neuropathol Commun. 2024; 12(1):190.

PMID: 39696694 PMC: 11654382. DOI: 10.1186/s40478-024-01906-9.


Mendelian randomization analysis of causal and druggable circulating inflammatory proteins in schizophrenia.

Cao H, Fu L, Liu D, Baranova A, Zhang F Front Psychiatry. 2024; 15:1465291.

PMID: 39544374 PMC: 11560794. DOI: 10.3389/fpsyt.2024.1465291.


Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model.

Horan-Portelance L, Iba M, Acri D, Gibbs J, Cookson M bioRxiv. 2024; .

PMID: 39372781 PMC: 11451628. DOI: 10.1101/2024.07.31.606032.


Spatial Multi-Omics in Alzheimer's Disease: A Multi-Dimensional Approach to Understanding Pathology and Progression.

Ma Y, Shi W, Dong Y, Sun Y, Jin Q Curr Issues Mol Biol. 2024; 46(5):4968-4990.

PMID: 38785566 PMC: 11119029. DOI: 10.3390/cimb46050298.

References
1.
Aman R, Ali Z, Butt H, Mahas A, Aljedaani F, Khan M . RNA virus interference via CRISPR/Cas13a system in plants. Genome Biol. 2018; 19(1):1. PMC: 5755456. DOI: 10.1186/s13059-017-1381-1. View

1.
Martins D, Moreira J, Goncalves N, Saraiva M . MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy. Dis Model Mech. 2017; 10(10):1253-1260. PMC: 5665453. DOI: 10.1242/dmm.028571. View

2.
Oblak A, Lin P, Kotredes K, Pandey R, Garceau D, Williams H . Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study. Front Aging Neurosci. 2021; 13:713726. PMC: 8346252. DOI: 10.3389/fnagi.2021.713726. View

3.
Wightman D, Jansen I, Savage J, Shadrin A, Bahrami S, Holland D . A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nat Genet. 2021; 53(9):1276-1282. PMC: 10243600. DOI: 10.1038/s41588-021-00921-z. View

3.
Yun S, Kim D, Kim S, Kim S, Karuppagounder S, Kwon S . α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegener. 2018; 13(1):1. PMC: 5759291. DOI: 10.1186/s13024-017-0233-5. View